Comparison of the AngioJet Rheolytic Catheter to Surgical Thrombectomy for the Treatment of Thrombosed Hemodialysis Grafts

Vesely, Thomas M.; Williams, David M.; Weiss, Mark A.; Hicks, Marshall E.; Stainken, Brian F.; Matalon, Terence A.S.; Dolmatch, Bart L.

doi:10.1016/s1051-0443(99)70220-4

Cited by 110 publications

(91 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…More recently, the development of mechanical thrombectomy devices changed even further the approach and management of thrombosed dialysis grafts. A number of devices and techniques have been developed for mechanical thrombus dissolution/maceration and/or aspiration [4][5][6][7][8].…”

Section: Discussionmentioning

confidence: 99%

“…Subsequently, other publications demonstrated equivalent efficacy of other devices when compared to thrombolytic therapy [5][6][7].…”

Section: Introductionmentioning

confidence: 97%

“…Accepted treatments for acutely occluded access grafts include surgery and thrombolytic therapy/angioplasty [3]. Several mechanical thrombectomy devices have been developed recently in efforts to lessen the invasiveness and cost of surgery and decrease complications related to thrombolytic therapy [4][5][6][7]. One of the first mechanical thrombectomy devices to be developed, and the first to be approved for the US market, was the Amplatz thrombectomy device (ATD); however, the final results in the trial comparing the ATD with surgical thromboembolectomy (ST) to declot occluded DAG had yet to be published.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Thrombosed dialysis access grafts: randomized comparison of the Amplatz thrombectomy device and surgical thromboembolectomy

et al. 2004

View full text Add to dashboard Cite

We report the final results of the trial comparing the Amplatz thrombectomy device (ATD) with surgical thromboembolectomy (ST) to declot thrombosed dialysis access grafts (DAG). The study population consisted of 174 DAG, 109 of which were randomized to mechanical thrombectomy using the ATD and 65 of which were randomized to conventional surgical thromboembolectomy. Forty grafts were re-enrolled in the trial when they failed beyond the 90 days follow-up after the initial treatment. Thirty-one were re-enrolled for mechanical thrombectomy and nine were re-enrolled for surgical thrombectomy, resulting in a total of 140 ATD procedures and 74 surgical thromboembolectomy. Immediate thrombectomy success was defined as greater than 90% thrombus removal followed by the ability to dialyze after treatment, and analysis of long term success based on graft patency at 30 and 90 days, with successful dialysis. Immediate thrombectomy success with the ATD procedure was achieved in 79.2% and with ST in 73.4%. Patency of the graft, with successful dialysis, at 30 days with the ATD procedure was 79.2% and with ST was 73.4%. Patency of the graft, with successful dialysis, at 90 days with the ATD procedure was 75.2% and with ST was 67.8%. The data collected in this study provided a prospective comparison of mechanical thrombectomy with the ATD and ST performance in thrombosed DAG. The results of the performance of both methods were comparable. No statistically significant differences were seen.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Subsequently, other publications demonstrated equivalent efficacy of other devices when compared to thrombolytic therapy [5][6][7].…”

Section: Introductionmentioning

confidence: 97%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Thrombosed dialysis access grafts: randomized comparison of the Amplatz thrombectomy device and surgical thromboembolectomy

et al. 2004

View full text Add to dashboard Cite

show abstract

“…Thus, a difference of at least 6 hours exists between the time window of the current therapy and timing of future, perhaps mechanical, therapies. Two recent reports [9,10] of mechanical removal of thrombus which was resistant to pharmacologic lysis, with subsequent improved patient outcome, highlights the principle and the necessity behind the development and testing of devices speci®cally designed for this purpose.…”

Section: Introductionmentioning

confidence: 99%

Photothermal properties of shape memory polymer micro‐actuators for treating stroke*

et al. 2002

View full text Add to dashboard Cite

show abstract

“…The AngioJet thrombectomy system has not only been used in thrombosed native vessels but also in hemodialysis grafts [20], and a single case of a PTFE aortorenal graft [21].…”

Section: Introductionmentioning

confidence: 99%

Revascularization of a thrombosed aortopulmonary shunt with the use of the AngioJet thrombectomy system

Donnelly

Ryan

2003

Cathet Cardio Intervent

View full text Add to dashboard Cite

We report the use of the AngioJet F140 rheolytic catheter to recannalize an acutely thrombosed aortopulmonary shunt in a 21-year-old female with palliated, complex congenital heart disease. After extracting the thrombus that filled the entire length of the shunt, three stents were placed at sites where the lumen was compromised by distortion or thrombus. Unobstructed flow was restored to the left pulmonary artery that persisted at 1-year follow-up.

show abstract

Comparison of the AngioJet Rheolytic Catheter to Surgical Thrombectomy for the Treatment of Thrombosed Hemodialysis Grafts

Cited by 110 publications

References 14 publications

Thrombosed dialysis access grafts: randomized comparison of the Amplatz thrombectomy device and surgical thromboembolectomy

Thrombosed dialysis access grafts: randomized comparison of the Amplatz thrombectomy device and surgical thromboembolectomy

Photothermal properties of shape memory polymer micro‐actuators for treating stroke*

Revascularization of a thrombosed aortopulmonary shunt with the use of the AngioJet thrombectomy system

Contact Info

Product

Resources

About